<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33660067</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1920</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Neuroradiology</Title><ISOAbbreviation>Neuroradiology</ISOAbbreviation></Journal><ArticleTitle>Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1481</StartPage><EndPage>1487</EndPage><MedlinePgn>1481-1487</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00234-021-02681-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The lifetime risk of developing amyotrophic lateral sclerosis (ALS) increases in the elderly, and greater age at symptom onset has been identified as a negative prognostic factor in the disease. However, the underlying neurobiological mechanisms are still poorly investigated. We hypothesized that older age at symptom onset would have been associated with greater extra-motor cortical damage contributing to worse prognosis, so we explored the relationship between age at symptom onset, cortical thinning (CT) distribution, and clinical markers of disease progression.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included 26 ALS patients and 29 healthy controls with T1-weighted magnetic resonance imaging (MRI). FreeSurfer 6.0 was used to identify regions of cortical atrophy (CA) in ALS, and to relate age at symptom onset to CT distribution. Linear regression analyses were then used to investigate whether MRI metrics of age-related damage were predictive of clinical progression. MRI results were corrected using the Monte Carlo simulation method, and regression analyses were further corrected for disease duration.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ALS patients exhibited significant CA mainly encompassing motor regions, but also involving the cuneus bilaterally and the right superior parietal cortex (p &lt; 0.05). Older age at symptom onset was selectively associated with greater extra-motor (frontotemporal) CT, including pars opercularis bilaterally, left middle temporal, and parahippocampal cortices (p &lt; 0.05), and CT of these regions was predictive of shorter survival (p = 0.004, p = 0.03).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">More severe frontotemporal CT contributes to shorter survival in older ALS patients. These findings have the potential to unravel the neurobiological mechanisms linking older age at symptom onset to worse prognosis in ALS.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferraro</LastName><ForeName>Pilar M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0002-5008-2791</Identifier><AffiliationInfo><Affiliation>Department of Neuroradiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. PilarMaria.Ferraro@ext.unige.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabona</LastName><ForeName>Corrado</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meo</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolla-Bigliani</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellan</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pardini</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inglese</LastName><ForeName>Matilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caponnetto</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roccatagliata</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>5 x 1000 2016</GrantID><Agency>Italian Ministry of Health</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Neuroradiology</MedlineTA><NlmUniqueID>1302751</NlmUniqueID><ISSNLinking>0028-3940</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000082643" MajorTopicYN="N">Cerebral Cortical Thinning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Age at onset</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cortical thinning</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Structural magnetic resonance imaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>4</Day><Hour>5</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33660067</ArticleId><ArticleId IdType="doi">10.1007/s00234-021-02681-3</ArticleId><ArticleId IdType="pii">10.1007/s00234-021-02681-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Longinetti E, Fang F (2019) Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol 32(5):771&#x2013;776. https://doi.org/10.1097/WCO.0000000000000730</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId><ArticleId IdType="pmc">6735526</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Barnwell J, Al-Chalabi A, Eisen A (2012) Young-onset amyotrophic lateral sclerosis: historical and other observations. Brain 135(Pt 9):2883&#x2013;2891. https://doi.org/10.1093/brain/aws144</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws144</ArticleId><ArticleId IdType="pubmed">22661746</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17(1):17&#x2013;23. https://doi.org/10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B (2003) Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60(7):1094&#x2013;1097. https://doi.org/10.1212/01.wnl.0000055861.95202.8d</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000055861.95202.8d</ArticleId><ArticleId IdType="pubmed">12682312</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin D, Lippa CF, Swearer JM (2007) Cognition and amyotrophic lateral sclerosis (ALS). Am J Alzheimers Dis Other Dement 22(4):300&#x2013;312. https://doi.org/10.1177/1533317507301613</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317507301613</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, Brunetti M, Ossola I, Lo Presti A, Cammarosano S, Canosa A, Chio A (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86(2):168&#x2013;173. https://doi.org/10.1136/jnnp-2013-307223</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307223</ArticleId><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E et al (2009) Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 10(5-6):310&#x2013;323. https://doi.org/10.3109/17482960802566824</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId><ArticleId IdType="pmc">3515205</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A, Moglia C, Lunetta C, Marinou K, Ticozzi N, Ferrante DG et al (2017) Factors predicting survival in ALS: a multicenter Italian study. J Neurol 264(1):54&#x2013;63. https://doi.org/10.1007/s00415-016-8313-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8313-y</ArticleId><ArticleId IdType="pubmed">27778156</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J, Kaufmann J, Fr&#xe4;drich J, Dengler R, Heinze HJ, Peschel T (2006) Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol 6:17. https://doi.org/10.1186/1471-2377-6-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-6-17</ArticleId><ArticleId IdType="pubmed">16638121</ArticleId><ArticleId IdType="pmc">1459868</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Ferraro PM, Riva N, Spinelli EG, Chio&#x2019; A, Canu E et al (2016) Structural brain correlates of cognitive and behavioral impairment in MND. Hum Brain Mapp 37(4):1614&#x2013;1626. https://doi.org/10.1002/hbm.23124</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23124</ArticleId><ArticleId IdType="pubmed">26833930</ArticleId><ArticleId IdType="pmc">6867462</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Kasper E, Machts J, Bittner D, Kaufmann J, Benecke R, Teipel S, Vielhaber S, Prudlo J (2014) Longitudinal course of cortical thickness decline in amyotrophic lateral sclerosis. J Neurol 261(10):1871&#x2013;1880. https://doi.org/10.1007/s00415-014-7426-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7426-4</ArticleId><ArticleId IdType="pubmed">25022938</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R, Westeneng HJ, Verstraete E, Hendrikse J, Veldink JH, van den Heuvel MP, van den Berg LH (2015) Cortical thickness in ALS: towards a marker for upper motor neuron involvement. J Neurol Neurosurg Psychiatry 86(3):288&#x2013;294. https://doi.org/10.1136/jnnp-2013-306839</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306839</ArticleId><ArticleId IdType="pubmed">25121571</ArticleId></ArticleIdList></Reference><Reference><Citation>Senda J, Atsuta N, Watanabe H, Bagarinao E, Imai K, Yokoi D, Riku Y, Masuda M, Nakamura R, Watanabe H, Ito M, Katsuno M, Naganawa S, Sobue G (2017) Structural MRI correlates of amyotrophic lateral sclerosis progression. J Neurol Neurosurg Psychiatry 88(11):901&#x2013;907. https://doi.org/10.1136/jnnp-2016-314337</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314337</ArticleId><ArticleId IdType="pubmed">28501822</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293&#x2013;299. https://doi.org/10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169(1-2):13&#x2013;21. https://doi.org/10.1016/s0022-510x(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer&#x2019;s dementia and normal aging. AJR Am J Roentgenol 149(2):351&#x2013;356. https://doi.org/10.2214/ajr.149.2.351</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/ajr.149.2.351</ArticleId><ArticleId IdType="pubmed">3496763</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 97(20):11050&#x2013;11055. https://doi.org/10.1073/pnas.200033797</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.200033797</ArticleId><ArticleId IdType="pubmed">10984517</ArticleId><ArticleId IdType="pmc">27146</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9(2):179&#x2013;194. https://doi.org/10.1006/nimg.1998.0395</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.1998.0395</ArticleId><ArticleId IdType="pubmed">9931268</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzapesa DM, D&#x2019;Errico E, Tortelli R, Distaso E, Cortese R, Tursi M, Federico F, Zoccolella S, Logroscino G, Dicuonzo F, Simone IL (2013) Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. PLoS One 8(11):e80748. https://doi.org/10.1371/journal.pone.0080748</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080748</ArticleId><ArticleId IdType="pubmed">24278317</ArticleId><ArticleId IdType="pmc">3835750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Bokde A, Elamin M, Byrne S, McLaughlin RL, Jordan N et al (2013) Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry 84(7):766&#x2013;773. https://doi.org/10.1136/jnnp-2012-302674</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-302674</ArticleId><ArticleId IdType="pubmed">23085933</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Zhang S, Jiang R, Gao F, Tang X, Zhu W (2018) Region-specific atrophy of precentral gyrus in patients with amyotrophic lateral sclerosis. J Magn Reson Imaging 47(1):115&#x2013;122. https://doi.org/10.1002/jmri.25765</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.25765</ArticleId><ArticleId IdType="pubmed">28591490</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow TW, Binns MA, Freedman M, Stuss DT, Ramirez J, Scott CJ et al (2008) Overlap in frontotemporal atrophy between normal aging and patients with frontotemporal dementias. Alzheimer Dis Assoc Disord 22(4):327&#x2013;335. https://doi.org/10.1097/WAD.0b013e31818026c4</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e31818026c4</ArticleId><ArticleId IdType="pubmed">18695590</ArticleId></ArticleIdList></Reference><Reference><Citation>Omer T, Finegan E, Hutchinson S, Doherty M, Vajda A, McLaughlin RL et al (2017) Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study. Amyotroph Lateral Scler Frontotemporal Degener 18(7-8):611&#x2013;623. https://doi.org/10.1080/21678421.2017.1332077</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1332077</ArticleId><ArticleId IdType="pubmed">28562080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Mioshi E, Burrell JR, Kiernan MC, Hodges JR, Hornberger M (2012) Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One 7(8):e43993. https://doi.org/10.1371/journal.pone.0043993</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043993</ArticleId><ArticleId IdType="pubmed">22952843</ArticleId><ArticleId IdType="pmc">3430626</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni M, Contarino VE, Catricala&#x2019; E, Dalla Bella E, Pensato V, Gellera C et al (2018) Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis. Neuroimage Clin 19:675&#x2013;682. https://doi.org/10.1016/j.nicl.2018.05.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.05.020</ArticleId><ArticleId IdType="pubmed">30023173</ArticleId><ArticleId IdType="pmc">6046611</ArticleId></ArticleIdList></Reference><Reference><Citation>Shellikeri S, Myers M, Black SE, Abrahao A, Zinman L, Yusunova Y (2019) Speech network regional involvement in bulbar ALS: a multimodal structural MRI study. Amyotroph Lateral Scler Frontotemporal Degener 20(5-6):385&#x2013;395. https://doi.org/10.1080/21678421.2019.1612920</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1612920</ArticleId><ArticleId IdType="pubmed">31088163</ArticleId><ArticleId IdType="pmc">6648678</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinn H, Abeliovich A (2017) Differential aging analysis in human cerebral cortex identifies variants in TMEM106B and GRN that regulate aging phenotypes. Cell Syst 4(4):404&#x2013;15.e5. https://doi.org/10.1016/j.cels.2017.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2017.02.009</ArticleId><ArticleId IdType="pubmed">28330615</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya VA, Patani R (2020) Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective. Brain 143(4):1057&#x2013;1072. https://doi.org/10.1093/brain/awz360</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz360</ArticleId><ArticleId IdType="pubmed">31851317</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>